Accessibility Menu
Psyched Wellness logo

Psyched Wellness(CNSX) PSYC

Market CapCA$2.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-97%
5 Year-97%
1 Year-75%
1 Month-50%
CA$0.01
+0.00%
+0.00Today
Psyched Wellness last closing stock price
MetricPriceDate
Last closeCAD 0.012026-08-31
Psyched Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%CAD 0.012026-08-19
1 month-50%CAD 0.012026-07-31
3 month-50%CAD 0.012026-06-02
Year to date-66.67%CAD 0.022025-12-30
1 year-75%CAD 0.022025-08-29
3 year-94.44%CAD 0.092023-09-01
5 year-97.14%CAD 0.182021-09-01
Since inception-96.55%CAD 0.152020-10-22

Psyched Wellness Financials at a Glance

Market Cap

CA$2.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$746.40K

Net Income (TTM)

-CA$5.37M

EPS (TTM)

-CA$0.02

P/E Ratio

-0.29

Dividend

CA$0.00

Beta (Volatility)

1.07 (Average)

Price

CA$0.01

Volume

5,000

Open

CA$0.01

Previous Close

CA$0.01

Daily Range

CA$0.01 - CA$0.01

52-Week Range

CA$0.01 - CA$0.03

Estimated Earnings Date

Apr 28, 2025

PSYC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psyched Wellness

Psyched Wellness Ltd. is a health supplements company focused on the production and distribution of artisanal medicinal mushrooms and related consumer packaged goods. Established in 2019, the company aims to enhance wellness through innovative products, including its flagship Amanita Muscaria Tincture.

Products and Services
  • Amanita Muscaria Tincture for stress relief and restorative sleep
  • Artisanal medicinal mushrooms in various forms
  • Consumer packaged goods designed for health and wellness
Growth Outlook
  • Market demand for health supplements is increasing significantly
  • Expansion into new markets is planned for the upcoming year
  • Innovative product development is underway to attract diverse consumers
Financial Highlights
  • Recent quarterly revenue of 177,827 CAD shows potential for growth
  • Cash and cash equivalents totaled 605,046 CAD as of May 31, 2026
  • Current ratio of 5.84 indicates strong short-term financial health
Psyched Wellness Ltd. operates in the growing health supplements sector, leveraging the increasing consumer interest in natural wellness solutions. The company's flagship product, the Amanita Muscaria Tincture, is designed to address various health concerns, including stress and sleep issues. With a focus on artisanal quality, Psyched Wellness aims to differentiate itself in a competitive market. The growth outlook for Psyched Wellness is promising, driven by rising demand for health supplements and plans for market expansion. The company is also committed to innovation, which may lead to new product offerings that cater to a broader audience. Financially, the company has shown resilience, with a recent quarterly revenue of 177,827 CAD, indicating a potential upward trend. The cash position remains solid, with 605,046 CAD in cash and cash equivalents, providing a buffer for operational needs. The current ratio of 5.84 suggests that the company is well-positioned to meet its short-term obligations, reflecting a strong financial foundation. Overall, Psyched Wellness Ltd. presents an intriguing opportunity for investors interested in the health and wellness sector, particularly in the context of growing consumer preferences for natural and artisanal products.
AI Generated • Aug 11, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Jeff Stevens

Website

www.psyched-wellness.com

Headquarters

Toronto, ON M5C 2C5, CA

PSYC Financials

Key Financial Metrics (TTM)

Gross Margin

-82.84%

Operating Margin

-761.26%

Net Income Margin

-719.79%

Return on Equity

-196.58%

Return on Capital

-163.82%

Return on Assets

-263.48%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$2.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

407.72M

Volume

5.00K

Avg. Volume

56.74K

Financials (TTM)

Gross Profit

-CA$618.28K

Operating Income

-CA$5.68M

EBITDA

-CA$5.91M

Operating Cash Flow

-CA$4.42M

Capital Expenditure

CA$4.00

Free Cash Flow

-CA$4.41M

Cash & ST Invst.

CA$605.05K

Total Debt

CA$0.00

Psyched Wellness Performance Analysis

Psyched Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30CAD 14,274N/A
20232023-11-30CAD 321,0962149.5%
20242024-11-30CAD 623,15694.1%
20252025-11-30CAD 472,302-24.2%
Psyched Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-08-31146.5%
Q42025-11-3028.2%
Q12026-02-2827.3%
Q22026-05-31-25.0%
Psyched Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30CAD -0.03-11.6%
20232023-11-30CAD -0.02-33.5%
20242024-11-30CAD -0.02-15.1%
20252025-11-30CAD -0.02-3.3%
Psyched Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-08-3133.9%
Q42025-11-30-4.9%
Q12026-02-28-7.0%
Q22026-05-318.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$177.83K

+201.6%

Gross Profit

-CA$299.11K

-1337.5%

Gross Margin

-1.68%

N/A

Market Cap

CA$2.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$1.13K

N/A

Employees

1,800

N/A

Net Income

-CA$1.62M

+9.2%

EBITDA

-CA$1.63M

-18.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$605.05K

-86.4%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$40.95K

-36.5%

Inventory

CA$1.37M

+88.5%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

N/A

Return on Assets

-2.63%

N/A

Return on Invested Capital

-3.36%

N/A

Free Cash Flow

-CA$930.02K

+42.5%

Operating Cash Flow

-CA$930.02K

+42.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BABY.TOElse Nutrition Holdings Inc.
CA$0.02-20.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About PSYC

What is the current price of Psyched Wellness?

Psyched Wellness is trading at CA$0.01 per share.

What is the 52-week range for Psyched Wellness?

Over the past 52 weeks, Psyched Wellness has traded between CA$0.01 and CA$0.03.

How much debt does Psyched Wellness have?

As of the most recent reporting period, Psyched Wellness reported total debt of CA$0.00.

How much cash does Psyched Wellness have on hand?

Psyched Wellness reported CA$605.05K in cash and cash equivalents in its most recent financial results.

What is Psyched Wellness’s dividend yield?

Psyched Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services